Are clinical trials safe?

Yes. Every study on QualifiedStudies is reviewed and approved by an Institutional Review Board (IRB) and conducted under FDA regulations. Research sites are HIPAA-covered entities, and you can withdraw at any time for any reason.

Do I get paid to participate in a clinical trial?

Most studies offer compensation for your time and travel. The amount varies by study length and visit schedule, and is disclosed up front before you enroll.

Is my health information kept private?

Yes. Your information is encrypted, never sold, and only shared with the specific research site you choose to apply to. Our handling of your data is governed by our Consumer Health Data Privacy Policy; the research sites you're matched with are HIPAA-covered entities.

How do I qualify for a clinical trial?

Take our free 60-second eligibility quiz. Enter your ZIP code, condition, and a few health details, and we'll match you with research sites near you that are actively enrolling participants.

Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

NCT ID: NCT07795593
Registry status: Not yet recruiting
Study type: Not specified in the registry data
Phase: Phase 4
Sponsor: University of Michigan

Overview

ClinicalTrials.gov lists this study as Not yet recruiting.

Enrollment: 600 participants (Estimated).

What is being studied

No interventions are listed in the registry data.

Who may be eligible

Ages: Not specified in the registry data
Sex: Not specified in the registry data
Healthy volunteers accepted: No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: * Diabetes * Painful Diabetic Neuropathy (confirmed at screening visit) * Willing to accept random treatment assignment to any of the proposed interventions Exclusion Criteria: * Pregnancy or plans to become pregnant during the study * History of neuropathy from causes other than diabetes as determined through medical and family history, physical and neurologic examinations * HbA1c \>10% * Participation in an experimental medication trial within 3 months of starting the study * Undergoing therapy for malignant disease other than basal-cell or squamous-cell skin cancer * Medical or psychiatric reason for not being a study candidate according to the site PI's discretion * Contraindications preventing trialing two interventions within any of the 3 modalities * Cirrhosis of the liver

Study locations

23 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: United States

California, United States: 1
Florida, United States: 1
Illinois, United States: 1
Iowa, United States: 1
Louisiana, United States: 1
Maryland, United States: 1
Michigan, United States: 1
Minnesota, United States: 3
Missouri, United States: 1
Nebraska, United States: 1
New York, United States: 2
North Carolina, United States: 2
Oregon, United States: 1
Pennsylvania, United States: 1
Tennessee, United States: 2
Texas, United States: 2
Wisconsin, United States: 1

Sample of listed locations

Stanford University — Stanford, California, 94305, United States — Site recruitment status not specified in the registry data
University of Florida-Jacksonville — Jacksonville, Florida, 32209, United States — Site recruitment status not specified in the registry data
Rush University Medical Center — Chicago, Illinois, 60612, United States — Site recruitment status not specified in the registry data
University of Iowa — Iowa City, Iowa, 52242, United States — Site recruitment status not specified in the registry data
Tulane University — New Orleans, Louisiana, 70118, United States — Site recruitment status not specified in the registry data
Johns Hopskins University — Baltimore, Maryland, 21224, United States — Site recruitment status not specified in the registry data
University of Michigan — Ann Arbor, Michigan, 48104, United States — Site recruitment status not specified in the registry data
Allina Health-Neurosciences Research — Minneapolis, Minnesota, 55407, United States — Site recruitment status not specified in the registry data
University of Minnesota — Minneapolis, Minnesota, 55455, United States — Site recruitment status not specified in the registry data
Mayo Clinic Rochester — Rochester, Minnesota, 55902, United States — Site recruitment status not specified in the registry data
University of Missouri — Columbia, Missouri, 65201, United States — Site recruitment status not specified in the registry data
University of Nebraska — Omaha, Nebraska, 68198, United States — Site recruitment status not specified in the registry data
Columbia University — New York, New York, 10027, United States — Site recruitment status not specified in the registry data
Will Cornell Medicine — New York, New York, 10065, United States — Site recruitment status not specified in the registry data
University of North Carolina — Chapel Hill, North Carolina, 27599, United States — Site recruitment status not specified in the registry data
Duke University — Durham, North Carolina, 27708, United States — Site recruitment status not specified in the registry data
Oregon Health & Science University — Portland, Oregon, 97239, United States — Site recruitment status not specified in the registry data
University of Pittsburgh — Titusville, Pennsylvania, 16354, United States — Site recruitment status not specified in the registry data
Meharry Medical College — Nashville, Tennessee, 37208, United States — Site recruitment status not specified in the registry data
University of Vanderbilt — Nashville, Tennessee, 37235, United States — Site recruitment status not specified in the registry data
DHR Health Institute for Research and Development — Edinburg, Texas, 78539, United States — Site recruitment status not specified in the registry data
BaylorScott & White University Medical Center — McKinney, Texas, 75071, United States — Site recruitment status not specified in the registry data
Essentia Health — Spooner, Wisconsin, 54801, United States — Site recruitment status not specified in the registry data

Study details

Start date: September 1, 2026
Primary completion date: August 1, 2030
First posted: August 31, 2026

Source and update information

Source: ClinicalTrials.gov
NCT ID: NCT07795593
Registry last updated: August 31, 2026
QualifiedStudies registry data refreshed: September 21, 2026

View NCT07795593 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Diabetic Neuropathy studies | Clinical trial FAQ